Neimeth International Pharmaceuticals Plc has commenced a Rights Issue program for a total of 2,373,947,500 ordinary shares of 50 kobo each at N1.55k.  On The Basis of Five (5) New Ordinary Shares For Every (4) Ordinary Share Held.  The below timelines have been set for acceptance of the offers:

Acceptance list opens: August 3, 2022

Acceptance list closes: August 25, 2022

Neimeth International Pharmaceuticals PLC is a publicly listed pharmaceutical company founded in 1997 and headquartered in Lagos. It was established by a former managing director of Pfizer Products of Nigeria to acquire some of the trading assets of Pfizer International in Nigeria.